Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BAX · NYSE · Health Care Equipment
Baxter International (BAX) · oqro.io/stocks/BAX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
No open-market purchase by an insider of Baxter International was filed in the last 90 days. The latest on record was on Mar 30, 2020.
Since 2006, Baxter International insiders reported 12 open-market purchases and 427 sales on Forms 4 and 5, with purchases in 6 different years, most recently 2020.
No open-market sale by an insider of Baxter International (BAX) was filed with the SEC in the last 90 days.
Yes. Members of Congress disclosed 3 trades in Baxter International (BAX) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent is from Rep. Lisa C. McClain (MI09).
Baxter International's next results are expected on Feb 10, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
$25.39−0.77 (−2.94%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day
+43.5% (+$7.70) from Nov 19, 2025 to Nov 19, 2026 · adjusted daily closes
Adjusted close went from $17.69 on Nov 19, 2025 to $25.39 on Nov 19, 2026 (+43.5%). Disclosed in this range: 0 insider trades, 0 pre-arranged insider sales, 0 Congress trades, and 26 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Equipment company based in Deerfield, Illinois.
Last 12 months
+43.5%
Market value
$13.2B
S&P 500 +8.0% over the same dates. Prices adjusted for splits and dividends.
Short interest: 23.7M shares sold short (4.5% of shares outstanding), −0.4% vs the previous count, 3.0 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.
Revenue
$2.98B
+5.0% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
—
Debt —, cash $1.98B, at Sep 30, 2026
Backlog
$7.58B
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 29, 2026.
Revenue, fiscal 2025
$11.2B
+5.7% vs the year before
Net income, fiscal 2025
−$957M
A loss for the year
Shares outstanding
517M
As of Oct 22, 2026
In fiscal 2025 the company spent $348M on dividends. Cash actually paid, from its cash-flow statement.
Next ex-dividend date Nov 27, 2026: $0.01 a share (quarterly), payable Jan 4, 2027. Calendar
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
15 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
15 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
15 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 13, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Insiders of Baxter International reported 12 open-market purchases and 427 sales since 2006; purchases in 6 different years, most recently 2020.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $2.62M1×1 trade |
| 2023 | — | $2.96M3×3 trades |
| 2022 | — | $5.82M12×12 trades |
| 2021 | — | $5.01M6×6 trades |
| 2020 | $804K1×1 trade | $21.4M18×18 trades |
| 2019 | — | $392M19×19 trades |
| 2018 | — | $576M24×24 trades |
| 2017 | — | $929M19×19 trades |
| 2016 | $500K1×1 trade | $1.32M8×8 trades |
| 2015 | — | $1.48M5×5 trades |
| 2014 | $19K4×4 trades | $6.07M10×10 trades |
| 2013 | $28K2×2 trades | $80M19×19 trades |
| 2012 | — | $17.8M13×13 trades |
| 2011 | — | $40.8M10×10 trades |
| 2010 | — | $15.8M7×7 trades |
| 2009 | — | $21M11×11 trades |
| 2008 | $378K2×2 trades | $26.1M175×175 trades |
| 2007 | — | $14.9M41×41 trades |
| 2006 | $25K2×2 trades | $3.62M26×26 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Top officer leaving
“Appointment of Andrew Hider as Interim CFO As previously announced, Anita Zielinski, the Company’s Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller, will depart the Company, effective as of September 15, 2026.”
8-K on sec.govTop officer leaving
“(the “Company”) of her decision to resign as the Company’s Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller, effective as of September 15, 2026, to join another company.”
8-K on sec.govTop officer leaving
“(the “Company”) of his decision to resign as the Company’s Executive Vice President and Group President, Pharmaceuticals, effective as of December 1, 2025, to join a company in the healthcare industry.”
8-K on sec.govTop officer leaving
“(the “Company”) of her decision to resign as the Company’s Executive Vice President, Chief Operating Officer (“COO”) and interim group president of Medical Products and Therapies (“MPT”), effective as of October 29, 2025 (the “Transition Date”), to join a company in the healthcare industry.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
On the public record for Baxter International over the 12 months to Nov 18, 2026: 60 FDA records (7th most among listed companies) and 1 securities case.
People read Baxter International's Wikipedia article about 110 times a day over the last week, fewer than the 150 on a usual day of the three months before.
A securities lawsuit naming the company as a defendant was filed on Dec 3, 2025 in the U.S. District Court, N.D. Illinois. A filing is an allegation, not a finding.
City of Hallandale Beach Police Officers' and Firefighters' Personnel Retirement Trust v. Baxter International, Inc., 1:25-cv-14712A securities lawsuit naming the company as a defendant was filed on Oct 16, 2025 in the U.S. District Court, N.D. Illinois. A filing is an allegation, not a finding.
Electrical Workers Pension Fund, Local 103 IBEW v. Baxter International, Inc., 1:25-cv-12672Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). Coverage of court records is not complete, and shareholder derivative suits are not included.
May 14, 2026Busiest day: 270 views on Aug 28, 2026Nov 19, 2026
Views of the article Baxter International, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
These are SEC announcements. Charges in a complaint or an order instituting proceedings are allegations; quoted text is the SEC's own wording. Listed when the company is named as a respondent under its exact legal name, or by the CIK or ticker the SEC states. Actions against subsidiaries or former names are not listed. Source: SEC.gov litigation releases, administrative proceedings and trading suspensions, checked Nov 19, 2026.
Last results
Oct 29, 2026
Within the 30 days after it, until Nov 28, 2026
Next results, expected
Feb 10, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From Baxter International's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Baxter International's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.
PZENA INVESTMENT MANAGEMENT LLC
13G · passive · Down from 13.8% · 65.3M shares · filed Apr 21, 2026
Dodge & Cox
13G · passive · Amended · 57.4M shares · filed Nov 13, 2025
FMR LLC
13G · passive · Up from 9% · 53M shares · filed Jun 5, 2026
Vanguard Capital Management
13G · passive · Crossed 5% · 38M shares · filed Apr 29, 2026
BlackRock, Inc.
13G · passive · Amended · 33.1M shares · filed Apr 27, 2026
BlackRock Portfolio Management LLC
13G · passive · Down from 8.7% · 30.4M shares · filed Oct 27, 2026
Recent moves
BlackRock Portfolio Management LLC cut its stake to 5.9% from 8.7% · Schedule 13G, 2026
FMR LLC raised its stake to 10.3% from 9% · Schedule 13G, 2026
FMR LLC raised its stake to 9% from 6.8% · Schedule 13G, 2026
Vanguard Capital Management went above 5%, with 7.36% · Schedule 13G, 2026
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
The three months Jul 1, 2026 to Sep 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Oct 29, 2026. Quarterly reports are not audited. Read the filing
+6.3% on the same quarter a year earlier ($1.98B). Operating income $439M, a 21% margin
+4.3% on the same quarter a year earlier ($773M). Operating income $139M, a 17% margin
The segments reach the total once $68M of items outside them is counted: corporate items, and the removal of sales between segments so they are not counted twice, as the company reports them.
Short sale volume: 63.5% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 61.1%. FINRA daily files, to Nov 19, 2026.
Fails to deliver: 113K shares (about $2.68M) were not delivered on time for settlement on Oct 2, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 38.6% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (24.3% on ATS, 14.3% with other brokers), close to its 26-week average of 38.2%. Weeks of Oct 5 to Oct 30, 2026.
PZENA INVESTMENT MANAGEMENT LLC cut its stake to 12.7% from 13.8% · Schedule 13G, 2026
+3.3% on the same quarter a year earlier ($1.54B)
+7.0% on the same quarter a year earlier ($1.29B)
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 12, 2026. Read the filing
+1.8% on the year before ($5.21B). Operating income $970M, a 18% margin
+4.1% on the year before ($2.95B). Operating income $441M, a 14% margin
+3.4% on the year before ($2.41B). Operating income $222M, a 9% margin
The segments reach the total once $381M of items outside them is counted: corporate items, and the removal of sales between segments so they are not counted twice, as the company reports them.
+4.6% on the year before ($5.85B)
+8.5% on the year before ($3.44B)
+3.3% on the year before ($1.35B)
The company also reports Non-US ($5.12B), which group lines above and are not added again.
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 15,000 words.
Baxter International Inc. is a global medical technology with approximately 37,500 employees worldwide who are engaged in the development, manufacture and sale of a broad range of products, digital health solutions and therapies used by hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices and patients at home under physician supervision. Our global footprint and the critical nature of our products and services, which are sold in over 100 countries as of December 31, 2025, play a key role in expanding access to healthcare in emerging and developed countries.
And 26 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 12, 2026 and Form 10-Q filed Oct 29, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
Largest ATS: INTELLIGENT CROSS LLC (14.2%), MS TRAJECTORY CROSS (ATS-1) (12.2%), UBS ATS (9.2%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Congress
Funds and stakes
Contracts, lobbying and filings
Latest annual report filed Feb 12, 2026, compared with the one filed Feb 21, 2025. Read the filing
And 1 more heading in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 12, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Company reports, price and press
Who holds it
Attention
Things to keep in mind
15 approvals or clearances and 46 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
Against the S&P 500 over the year
Since Nov 18, 2025, BAX is up 39.9% and the index fund is up 8.5%: 31 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much BAX moves
Beta 1.1 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).